Gladstone in the News
December 13, 2020
Forbes—In an article about the need for rapid testing to monitor and curb the COVID-19 pandemic, Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, explains the advantages of the CRISPR- and smartphone-based detection platform she developed with Senior Investigator and Nobel Laureate Jennifer Doudna, PhD, and UC Berkeley Professor Dan Fletcher, PhD.
Gladstone Experts
COVID-19
Data Science and Biotechnology
Virology
Doudna Lab
Ott Lab
Gladstone in the News
December 11, 2020
San Francisco Business Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, discusses the rapid, smartphone-based Coronavirus detection assay her group recently described in the scientific publication Cell. The assay was developed by Graduate Student Parinaz Fozouni, in collaboration with the labs of Senior Scientist and Nobel Laureate Jennifer Doudna, PhD, and of UC Berkeley Bioengineering Professor Dan Fletcher, PhD.
Gladstone Experts
COVID-19
Data Science and Biotechnology
Virology
Doudna Lab
Ott Lab
Gladstone in the News
November 17, 2020
San Francisco Chronicle—Associate Investigator Nadia Roan, PhD, comments on recent findings by her group and others that COVID-19 patients retain immune cells against the new coronavirus for several months after infection, which bodes well for the ability of vaccines to provide lasting protection against the disease.
Gladstone Experts
COVID-19
Virology
Roan Lab
Gladstone in the News
November 13, 2020
The Wall Street Journal—Chief Information Officer Scott Pegg explains how his IT team adapted quickly to the COVID-19 pandemic to provide Gladstone researchers with the computing and storage power they needed to work on large data sets—in particular image data—from their homes.
Information Technology
Gladstone Experts
Gladstone in the News
November 5, 2020
Nature—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, explains how the CRISPR-based coronavirus test she recently developed with Nobel Laureate and Senior Investigator Jennifer Doudna, PhD, measures up against conventional, PCR-based tests.
Gladstone Experts
COVID-19
Virology
Doudna Lab
Ott Lab
CRISPR/Gene Editing
Gladstone in the News
November 1, 2020
USA Today—California Proposition 14 put funding for the Stem Cell Research Institute on the ballot this year. Gladstone President Deepak Srivastava, MD, explains how previous funding for stem cell research in California has helped bring the field to a point where stem cell–based therapies are now possible.
Gladstone Experts
Cardiovascular Disease
Srivastava Lab
Stem Cells/iPSCs
Gladstone in the News
October 30, 2020
TED—In a March talk selected this week for the TED homepage, Senior Investigator Leor Weinberger, PhD, describes an intriguing type of vaccine his lab is developing and that, like the viruses it aims to neutralize, can mutate and spread from person to person.
Gladstone Experts
HIV/AIDS
Center for Cell Circuitry
Virology
Weinberger Lab
Gladstone in the News
October 28, 2020
USA Today—Senior Investigator and Nobel Laureate Jennifer Doudna, PhD, shares her view of CRISPR-based coronavirus detection kits and the possibility they might be deployed during the current pandemic. She and Senior Investigator Melanie Ott, MD, PhD, recently described the test they developed together in a publication posted on the electronic preprint platform bioRxiv.
Gladstone Experts
COVID-19
Data Science and Biotechnology
Virology
Doudna Lab
Ott Lab
CRISPR/Gene Editing